Behavioral interventions: Immunologic mediators and disease outcomes

Psychoneuroimmunology, Two-Volume Set

Volumn 1, Issue , 2007, Pages 675-703

  Antoni, Michael H ^a   Schneiderman, Neil ^a   Penedo, Frank ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882563654     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088576-3/50038-1     Document Type: Chapter

References (278)

1. Ackerman K., Felten S., Dijkstra C., Livnat S., Felten D. Parallel development of noradrenergic innervation and cellular comPARTmentation in the rat spleen. Exp. Neurol. 1989, 103:S239.
2. Ader R. Role of conditioning in the pharmacotherapy of autoimmune diseases. Mind-body interactions and disease and psychoneuroimmunological aspects of health and disease 1996, 295-300. Heath Dateline Press, Washington, DC. N. Hall, F. Altman, S. Blumenthal (Eds.).
3. Ader R., Felten D., Cohen N. Psychoneuroimmunology 1991, Academic Press, New York. 2nd ed.
4. Affleck G., Urrows S., Tennen H., Higgins P., Pav D., Aloisi R. A dual pathway model of daily stressor effects on rheumatoid arthritis. Ann. Behav. Med. 1997, 19:161-170.
5. Altemus M., Rao B., Dhabhar F., Ding W., Granstein R. Stress-induced changes in skin barrier function in healthy women. J. Invest. Dermatol. 2001, 117:309-317.
6. Andersen B., Farrar W., Golden-Kreutz D., Kutz L., MacCallum R., Courtney M., Glaser R. Stress and immune responses after surgical treatment for regional breast cancer. J. NCI 1998, 90:30-36.
7. Andersen B., Farrar W., Golden-Kreutz D., Glaser R., Emery C., Crespin T., Shapiro C., Carlson W. Psychological, behavioral, and immune changes after a psychosocial intervention: a clinical trial. J. Clin. Oncol. 2004, 22:3570-3580.
8. Andersen B., Kiecolt-Glaser J., Glaser R. A biobehavioral model of cancer stress and disease course. Am. Psychol. 1994, 49:389-404.
9. Antoni M.H., Lutgendorf S., Ironson G., Fletcher M.A., Schneiderman N. CBSM intervention effects on social support, coping, depression and immune function in symptomatic HIV-infected men. the American Psychosomatic Society 1996, March, Paper presented at.
10. Antoni M.H. Cognitive behavioral stress management for gay men learning of their HIV-1 antibody test results. Group therapy for patients with chronic medical diseases 1997, 55-91. Guilford Press, New York. J. Spira (Ed.).
11. Antoni M.H., Lufgendorf S., Cole S.W., Dhabhar F.S., Sephton S.E., McDonald P.G., Stefanek M., Sood A. The influence of biobehavioral factors on tumor biology: pathways and mechanisms. Nature Reviews Cancer 2006, 6:240-248.
12. Antoni M.H. Psychoneuroendocrinology and psychoneuroimmunology of cancer: plausible mechanisms worth pursuing?. Brain Behav. Immun. 2003, 17:S84-S91.
13. Antoni M.H. Stress management effects on psychological, endocrinological and immune function in men with HIV: empirical support for a psychoneuroimmunological model. Stress 2003, 6:173-188.
14. Antoni M.H. Stress management intervention for women with breast cancer 2003, American Psychological Association Press, Washington, DC.
15. Antoni M.H., Baggett L., Ironson G., August S., LaPerriere A., Klimas N., Schneiderman N., Fletcher M.A. Cognitive-behavioral stress management intervention buffers distress responses and immunologic changes following noti-fication of HIV-1 seropositivity. J. Consult. Clin. Psychol. 1991, 6:906-915.
16. Antoni M.H., Caricco A., Duran R., Spitzer S., Penedo F., Ironson G., Fletcher M.A., Klimas N., Schneiderman N. Randomized Clinical Trial of Cognitive Behavioral Stress Management on HIV Viral Load in Gay Men Treated with HAART. Psychosom. Med. 2006, 68(1):143-151.
17. Antoni M.H., Cruess S., Cruess D., Kumar M., Lutgendorf S., Ironson G., Dettmer E., Williams J., Klimas N., Fletcher M.A., Schneiderman N. Cognitive behavioral stress management reduces distress and 24-hour urinary free cortisol among symptomatic HIV-infected gay men. Ann. Behav. Med. 2000, 22:1-11.
18. Antoni M.H., Cruess D., Klimas N., Maher K., Cruess S., Kumar M., Lutgendorf S., Ironson G., Schneiderman N., Fletcher M.A. Stress management and immune system reconstitution in symptomatic HIV-infected gay men over time: effects on transitional naïve T-cells (CD4+CD45RA+CD29+) A. J. Psychiatry 2002, 159:143-145.
19. Antoni M.H., Cruess D., Klimas N., Maher K., Cruess S., Lechner S., Carrico A., Kumar M., Lutgendorf S., Ironson G., Fletcher M.A., Schneiderman N. Increases in a marker of immune system reconstitution are predated by decreases in 24-hour urinary cortisol output and depressed mood during a 10-week stress management intervention in symptomatic gay men. J. Psychosom. Res. 2005, 58:3-13.
20. Antoni M.H., Cruess D., Wagner S., Lutgendorf S., Kumar M., Ironson G., Klimas N., Fletcher M.A., Schneiderman N. Cognitive behavioral stress management effects on anxiety, 24-hour urinary catecholamine output, and T-cytotoxic/ suppressor cells over time among symptomatic HIV-infected gay men. J. Consult. Clin. Psychol. 2000, 68:31-45.
21. Antoni M.H., Goodkin K. Life stress and moderator variables in the promotion of cervical neoplasia. I: Personality facets. J. Psychosom. Research 1988, 32(3):327-338.
22. Antoni M.H., Goodkin K. Life stress and moderator variables in the promotion of cervical neoplasia. II: Life event dimensions. J. Psychosom. Res. 1989, 33(4):457-467.
23. Antoni M.H., Lehman J., Kilbourn K., Boyers A., Yount S., Culver J., Alferi S., McGregor B., Arena P., Harris S., Price A., Carver C.S. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances Benefit finding among women under treatment for earl breast cancer. Health Psychol. 2001, 20:20-32.
24. Antoni M.H., Schneiderman N. HIV/AIDS. Comprehensive clinical psychology 1998, 237-275. Elsevier Science, New York. A. Bellack, M. Hersen (Eds.).
25. Antoni M.H., Schneiderman N., Fletcher M., Goldstein D., LaPerriere A., Ironson G. Psychoneuroimmunology and HIV-1. J. Consult. Clin. Psychol. 1990, 58(1):38-49.
26. Antoni M.H., Wagner S., Cruess D., Kumar M., Lutgendorf S., Ironson G., Dettmer E., Williams J., Klimas N., Fletcher M.A., Schneiderman N. Cognitive behavioral stress management reduces distress and 24-hour urinary free cortisol among symptomatic HIV-infected gay men. Ann. Behav. Med. 2000, 22:29-37.
27. Antoni M.H., Weiss D. Stress, immunity, and chronic fatigue syndrome: a conceptual model to guide the development of treatment and research. Handbook of chronic fatigue syndrome and fatiguing illnesses 2003, 527-545. John Wiley and Sons, New York. L. Jason, P. Fenell, R. Taylor (Eds.).
28. Appels A., Bar F.W., Bar J., Bruggeman C., de Bates M. Inflammation, depressive symptomatology, and coronary artery disease. Psychosom. Med. 2000, 62:601-605.
29. Auerbach J.E., Oleson T.D., Solomon G.F. A behavioral medicine intervention as an adjunctive treatment for HIVrelated illness. Psychol. Health 1992, 6:325-334.
30. Baron R., Cutrona C., Hicklin D., Russel D., Lubaroff D. Social support and immune function among spouses of cancer patients. J. Pers. Soc. Psychol. 1990, 59:344-352.
31. Barraclough J., Pinder P., Cruddas M., Osmond C., Taylor I., Perry M. Life events and breast cancer prognosis. Br. Med. J. 1992, 304:1078-1081.
32. Bartholomew J.S., et al. Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor c. Cancer Res. 1997, 57:937-942.
33. Bartrop R., Lazarus L., Luckhurst E., Kiloh L., Penny R. Depressed lymphocyte function after bereavement. Lancet 1977, 1:834-836.
34. Baxevanis C., Reclos G., Gritzapis A., Dedousis G., Missitzis I., Papamichail M. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in p with breast cancer. Cancer 1993, 72:491-501.
35. Beck L., D'Amore P.A. Angiogenesis and markers. FASEB J 1997, 5:365-373.
36. Beck A., Emery G. Cognitive therapy of anxiety and phobic disorders 1979, Center for Cognitive Therapy, Philadelphia, PA.
37. Bellinger D., Ackerman K., Felten S., Felten D. A longitudinal study of age-related loss of noradrenergic nerves and lymphoid cells in the aged rat spleen. Exp. Neurol. 1992, 116:295-311.
38. Bergers G., Benjamin L. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 2003, 3:401-410.
39. Berkenbosch F., Van Oers J., del Rey A., Tilders F., Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 1987, 238:524.
40. Berkman L.F., Blumenthal J., Burg M., Carney R.M., Catellier D., Cowan M.J., Czajkowski S.M., DeBusk R., Hosking J., Jaffe A., Kaufmann P.G., Mitchell P., Norman J., Powell L.H., Raczynski J.M., Schneiderman N. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the enhancing recovery in coronary heart disea (ENRICHD) randomized trial. JAMA 2003, 289:3106-3116.
41. Bernstein B., Borkovec T. Progressive muscle relaxation training: a manual for the helping professions 1973, Research Press, Champaign, IL.
42. Besedovsky H., del Rey, A.Sorkin E. Lymphokine containing supernatants from Con A-stimulated cells increase corticosterone blood levels. J. Immunol. 1981, 126:385.
43. Besedovsky H., del Rey A., Sorkin E., DaPrada M., Burri R., Honegger C. The immune response evokes changes in brain noradrenergic neurons. Science 1983, 221:564.
44. Biron G., Byron K., Sullivan J. Severe herpes virus infections in an adolescent without natural killer cells. N. Engl. J. Med. 1989, 320:1731-1735.
45. Bovjberg D. Psychoneuroimmunology: implications for oncology?. Cancer 1991, 67:828-832.
46. Bovbjerg D., Valdimarsdottir H. Stress, immune modulation, and infectious disease during chemotherapy for breast cancer. Ann. Behav. Med. 1996, 18:S63.
47. Breitbart W., Payne D. Pain. Textbook of psycho-oncology 1998, 450-467. New York: Oxford. J. Holland (Ed.).
48. Brenner B., Margolese R. The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer. Cancer 1991, 68:482-488.
49. Broadley A.J., Korszun A., Jones C.J., Frenneaux M.P. Arterial endothelial function is impaired in treated depression. Heart 2002, 88:521-523.
50. Brooks G.R., Richardson F.C. Emotional skills training: a treatment program for duodenal ulcer. Behav. Ther. 1980, 11:198-207.
51. Buchwald D., Cheney D., Peterson, et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus-type 6 infection. Ann. Int. Med. 1992, 116:103-113.
52. Burack J.H., Barrett D.C., Stall R.D., Chesney M.A., Ekstrand M.L., Coates T.J. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA 1993, 270:2567-2573.
53. Busse W., Kiecolt-Glaser J., Coe C. Stress and asthma: NHLBI workshop report. Am. J. Crit. Care Med. 1995, 248-252.. (January).
54. Byrnes D., Antoni M.H., Goodkin K., Efantis-Potter J., Simon T., Munajj J., Ironson G., Fletcher M.A. Stressful events, pessimism, natural killer cell cytotoxicity, and cytotoxic/ suppressor T-cells in HIV+ Black women at risk for cervical cancer. Psychosomat. Med. 1998, 60:714-722.
55. Calabrese J., Kling M., Gold P. Alterations in immunocompetence during stress, bereavement, and depression: focus on neuroendocrine regulation. Am. J. Psychiatry 1987, 144(9):1123-1134.
56. Carbonari M., Fiorilli M., Mezzaroma I., Cherichi M., Aiuti F. CD4 as the receptor for retroviruses of the HTLV family: immunopathogenetic implications. Adv. Exp. Med. Biol. 1989, 257:3-7.
57. Carlson S., Felten D., Livnat S., Felten S. Noradrenergic sympathetic innervation of the spleen. V. Acute drug-induced depletion of lymphocytes in the target fields of innervation results in redistribu noradrenergic fibers but maintenance of comPARTmentation. J. Neurosci. Res. 1987, 18:64-69.
58. Carney R.M., Freedland K.E., Miller G.E., Jaffe A.S. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J. Psychosom. Res. 1902, 53:897-902.
59. Carney R.M., Rich M.W., Tevelde A., Saini J., Clark K., Jaffe A.S. Major depressive disorder in coronary artery disease. Am. J. Cardiol. 1987, 60:1273-1275.
60. Carroll B.J., Reinberg M., Greden J.F., et al. A specific laboratory test for the diagnosis of melancholia: standardization, validation, and clinical utility. Arch. Gen. Psych. 1981, 38:15-22.
61. Case R.B., Moss A.J., Case N., McDermott M., Eberly S. Living alone after myocardial infarction. J. Am. Med. Assoc. 1992, 267:515-519.
62. Centers for Disease Control HIV/AIDS surveillance report 1997, 9(1):1-39.
63. Chrousos G., Gold P. The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA 1992, 267:1244-1252.
64. Chuang L., Lotzova E., Cook K., Cristoforoni P., Morris M., Wharton J. Effect of new investigational drug taxol on oncolytic activity and stimulation of human lymphocytes. Gynecol. Oncol. 1993, 49:291-298.
65. Classen C., Sephton E., Diamond S., Spiegel D. Textbook of psycho-oncology 1998, 730-742. New York: Oxford. J. Holland (Ed.).
66. Coffey R., Hadden E., Hadden J. Norepinephrine stimulation of membrane ATPase in human lymphocytes. Endocrinol. Res. Comm. 1975, 12:179.
67. Cohen S., Tyrrell D.A., Smith A.P. Psychological stress in humans and susceptibility to the common cold. N. Engl. J. Med. 1991, 325:606-612.
68. Cole S., Kemeny M., Naliboff B., Fahey J., Zack J. ANS enhancement of HIV pathogenesis. Brain Behav. Immun. 2001, 15:121.
69. Cole S., Kemeny M., Taylor S., Visscher B., Fahey J. Accelerated course of HIV infection in gay men who conceal their homosexuality. Psychosom. Med. 1996, 58:219-231.
70. Crary B., Borysenko M., Sutherland D., Kutz I., Borysenko J., Benson H. Decrease in mitogen responsiveness of mononuclear cells from peripheral blood after epinephrine administration in humans. J. Immunol. 1983, 130:694-697.
71. Crowther J.H. Stress management training and relaxation imagery in the treatment of essential hypertension. J. Behav. Med. 1983, 6:169-187.
72. Cruess D. Improving sleep quality in patients with chronic illness. Innovative approaches to health psychology: prevention and treatment lessons from AIDS 2002, 235-252. American Psychological Association Press, Washington, DC. M. Chesney, M. Antoni (Eds.).
73. Cruess D., Antoni M., Cruess S., Fletcher M., Ironson G., Kumar M., Hayes A., Klimas N., Schneiderman N. Cognitive-behavioral stress management increases free testosterone and decreases psychological distress in HIV-seropositive men. Health Psychol. 2000, 19(1):12-20.
74. Cruess S., Antoni M.H., Cruess D., Fletcher M.A., Ironson G., Kumar M., Lutgendorf S., Hayes A., Klimas N., Schneiderman N. Reductions in HSV-2 antibody titers after cognitive behavioral stress management and relationships with neuroendocrine function, relaxation skills, and social in HIV+ gay men. Psychosom. Med. 2000, 62:828-837.
75. Cruess D.G., Antoni M.H., McGregor B.A., Boyers A., Kumar M., Kilbourn K., Carver C.S. Cognitive-behavioral stress management reduces serum cortisol by enhancing positive contributions among women being treated for early stage breast cancer. Psychosom. Med. 2000, 62:304-308.
76. Cruess D., Antoni M.H., McGregor B., Kilbourn K., Boyers A., Alferi S., Carver C.S., Duran R., Kumar M. Cognitive behavioral stress management effects on testosterone and positive growth in women with early-stage breast cancer. Int. J. Behavl. Med. 2001, 8:194-207.
77. Cupps T., Fauci A. Corticosteroid-mediated immunoregulation in man. Immunol. Rev. 1982, 65:133-155.
78. Dantzer R. Cytokine-induced sickness behavior: where do we stand?. Brain Behav. Immun. 2001, 15:7-24.
79. Davies A., Lefkowitz R. Regulation of a-adrenergic receptors by steroid hormones. Ann. Rev. Physiol. 1984, 46:119-130.
80. De Beaurepaire R. Questions raised by the cytokine hypothesis of depression. Behav. Immun 2002, 16:610-617. Brain.
81. Demitrack M., Dale J., Straus S., Loue L., Listwak S., Kruesi M., Chrousos G., Gold P. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 1991, 73:1224-1234.
82. Duncan M., Sadlik J., Hadden J. Glucocorticoid modulation of lymphokine-induced macrophage proliferation. Cell. Immunol. 1982, 67:23-36.
83. Dusseldorp E., van Elderen T., Maes S., Meulman, Kraaij V. A meta-analysis of phychoeducational programs for coronary heart disease patients. Health Psychol. 1999, 18:506-519.
84. Engstrom C., Strohl R., Rose L., Lewandowski L., Stefanek M. Sleep alterations in cancer patients. Cancer Nurs. 1999, 22:143-148.
85. Esterling B., Antoni M.H., Fletcher M.A., Margulies S., Schneiderman N. Emotional disclosure through writing or speaking modulates latent Epstein-Barr Virus antibody titers. J. Consult. Clin. Psychol. 1994, 62:130-140.
86. Esterling B., Antoni M.H., Kumar M., Schneiderman N. Emotional repression, stress disclosure responses, and Epstein-Barr viral capsid antigen titers. Psychosom. Med. 1990, 52:397-410.
87. Esterling B., Antoni M.H., Schneiderman N., Carver C., LaPerriere A., Ironson G., Klimas N., Fletcher M. Psychosocial modulation of antibody to Epstein-Barr viral capsid antigen and Human Herpes Virus-Type 6 in HIV-1 infected and at-risk gay men. Psychosom. Med. 1992, 54:354-371.
88. Esterling B., Kiecolt-Glaser J., Bodnar J., Glaser R. Chronic stress, social support, and persistent alterations in the natural killer cell response to cytokines in older adults. Health Psychol. 1994, 13:291-298.
89. Esterling B., Kiecolt-Glaser J., Glaser R. Psychosocial modulation of cytokine-induced natural killer cell activity in older adults. Psychosom. Med. 1996, 58:264-272.
90. Fawzy F., Canada A., Fawzy N. Malignant melanoma: effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up. Arch. Gen. Psychiatry 2003, 60:100-103.
91. Fawzy F., Fawzy N., Hyun C., Elashoff R., Guthrie D., Fahey J., Morton D. Malignant melanoma, Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch. Gen. Psychiatry 1993, 50:681-689.
92. Fawzy F., Fawzy N., Hyun C., Wheeler J. Brief, copingoriented therapy for patients with malignant melanoma. Group therapy for medically ill patients 1997, 133-164. Guilford, New York. J. Spria (Ed.).
93. Fawzy F., Kemeny M., Fawzy N., Elashoff R., Morton D., Cousins N., Fawzy S. A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch. Gen. Psychiatry 1990, 47:729-735.
94. Feinberg B.B., Tan N.S., Gonik B., Brath P.C., Walsh S.W. Increased progesterone concentrations are necessary to suppress interleukin mediated cell cytotoxicity. Am. J. Obstet. Gynecol. 1991, 165:1872-1876.
95. Felten D. Changes in the neural innervation of lymphoid tissues with age. Mind-body interactions and disease and psychoneuroimmunological aspects of health and disease. Proceedings of conference on Stress, Immunity and Health. Natio Institutes of Health 1996, 157-164. Heath Dateline Press, Washington, DC. N. Hall, F. Altman, S. Blumenthal (Eds.).
96. Felten D., Felten S., Bellinger D., Carlson S., Ackerman K., Madden K., Olscowka J., Livnat S. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol. Rev. 1987, 100:225-260.
97. Fishman B., Loscalzo M. Cognitive-behavioral interventions in management of cancer pain: principles and applications. Med. Clin. North Am. 1987, 71(2):271-287.
98. Florijn Y., Geiger A. Community based physical activity program for HIV-1 infected persons. Proceedings of the Biological Aspects of HIV Infection Conference 1991.
99. Folkman S., Chesney M., McKusick L., Ironson G., Johnson D., Coates T. Translating coping theory into intervention. The social context of coping 1991, 239-259. Plenum, New York. J. Eckenrode (Ed.).
100. Fontanarosa P., Lundberg G. Complementary, alternative, unconventional, and integrative medicine. JAMA 1997, 278:2111-2112.
101. Fonteneau J.F., Le Drean E., Le Guiner S., Gervois N., Diez E., Jotereau F. Heterogeneity of biologic responses of melanoma-specific CTL. J. Immunol. 1997, 15:2831-2839.
102. Frasure-Smith N., Lésperance F., Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995, 91:999-1005.
103. Freedman L., Yoshinaga S., Vanderbilt J., Yamamoto K. In vitro transcription enhancement by purified derivatives of glucocorticoid receptor. Science 1989, 245:298-301.
104. Friedman M., Thoresen C.E., Gill J., Ulmer D., Powell L.H., et al. Alteration of Type A behavior and its effect on cardiac recurrences in postmyocardial infarction patients: summary results of the Recurrent Coronary Preventio. Am. Heart J. 1986, 112:653-665.
105. Gatenbeck L. Stress stimuli and the prostatic gland: An experimental study in the rat. Scandinavian Journal of Urology and Nephrology 1986, 99:1-11.
106. Ghiadoni L., Donald A.E., Cropley M., et al. Mental stress induces transient endothelial dysfunction in humans. Circulation 2000, 102:2473-2478.
107. Glaser R., Kennedy S., Lafuse W.P., Bonneau R.H., Speicher C.E., Kiecolt-Glaser J.K. Psychological stressinduced modulation of IL-2 receptor gene expression and IL-2 production in peripheral blood leukocytes. Arch. Gen. Psychiatry 1990, 47:707-712.
108. Glaser R., Kiecolt-Glaser J. Chronic stress modulates the virus-specific immune response to latent herpes simplex virus type 1. Ann. Behav. Med. 1997, 19:78-82.
109. Glaser R., Kiecolt-Glaser J.K., Bonneau R., Malarkey W., Hughes J. Stress-induced modulation of the immune response to recombinant hepatitis B vaccine. Psychosom. Med. 1992, 54:22-29.
110. Glaser R., Pearson G., Bonneau R., et al. Stress and the memory T-cell response to the Epstein-Barr Virus in healthy medical students. Health Psychol. 1993, 12:435-442.
111. Glaser R., Rice J., Sheridan J., Fertel R., Stout J., Speicher C., Pinsky D., Kotur M., Post A., Beck M., Kiecolt-Glaser J. Stress-related immune suppression: health implications. Brain Behav. Immun. 1987, 1:7-20.
112. Goebel M.U., Mills P.J. Acute psychological stress and exercise and changes in peripheral leukocyte adhesion molecule expression and density. Psychosom. Med. 2000, 62:664-670.
113. Goodkin K., Antoni M.H., Blaney P. Stress and hopelessness in the promotion of cervical intraepithelial neoplasia to invasive squamous cell carcinoma of the cervix. J. Psychosom. Res. 1986, 30(1):67-76.
114. Goodkin K., Antoni M.H., Fox B.H., Sevin B. A PARTially testable model of psychosocial factors in the etiology of cervical cancer. II. Psychoneuroimmunological aspects, critique and prospective integrat. Psycho-oncology 1993, 2(2):99-121.
115. Goodkin K., Baldewicz T., Asthana D., Khanis I., Blaney N., Kumar M., Burkhalter J., Leads B., Shapshak P. A bereavement support group intervention affects plasma burden of HIV-1. J. Hum. Virol. 2001, 4(1):44-54.
116. Goodkin K., Blaney N., Feaster D., Fletcher M.A. Active coping is associated with natural killer cell cytotoxicity in asymptomatic HIV-1 seropositive homosexual men. J. Psychosom. Res. 1992, 36(7):635-650.
117. Goodwin P., Leszcz M., Ennis M. The effect of group psychosocial support on survival in metastatic breast cancer. N. Engl. J. Med. 2001, 345:1719-1726.
118. Greer S. Psychological responses to cancer and survival. Psychol. Med. 1991, 21:43-49.
119. Greer S., Moorey S., Baruch J., Watson M., Robertson B., Mason A., Rowden L., Law M., Bliss J. Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. Br. Med. J. 1992, 304:675-680.
120. Greer S., Morris T., Pettingale K., Haybittle J. Psychological response to breast cancer and 15-year outcome 1990, 49-50. Lancet.
121. Gruber B., Hersh S., Hall N., Waletzky L., Kunz J., Carpenter J., Kverno K., Weiss S. Immunologic responses of breast cancer patients to behavioral interventions. Biofeedback and Self-Regulation 1993, 18:1-22.
122. Hadden J., Hadden E., Meetz G., Good R., Haddox M., Goldberg N. Cyclic GMP in cholinergic and mitogenic modulation of lymphocyte metabolism and proliferation. Fed. Proc. 1973, 32:1022.
123. Hadden J., Hadden E., Middleton E. Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes. J. Cell. Immunol. 1970, 1:583.
124. Hahne M., Rimoldi D., Schroter M., Romero P., Schreier M., French L., Schneider P., Bornand T., Fontana A., Lienard D. Melanoma cell expression of fas (Apo-1/ CD95) ligand: implications for tumor immune escape. Science 1996, 274:1363-1366.
125. Hall M., Baum A., Buysse D., Prigerson G., Kupfer D., Reynolds C. Sleep as a mediator of the stress-immune relationship. Psychosom. Med. 1998, 60:48-51.
126. Harbuz M.S., Chover-Gonzalez A.J., Jessop D.S. Hypothalamo-pituitary-adrenal axis and chronic immune activation. Ann. NY Acad. Sci. 2003, 992:99-106.
127. Heijnen C., Kavelaars A. Human psychoneuroimmunology 2005, 195-218. Oxford University Press, Oxford. K. Vedhara, M. Irwin (Eds.).
128. Hendrix M., Seftor E., Hess A., Seftor R. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat. Rev.: Cancer 2003, 3:411-421.
129. Herberman R., Holden H. Natural cell-mediated immunity. Adv. Cancer Res. 1978, 27:305-377.
130. Herbert T., Cohen S. Depression and immunity: A meta-analytic review. Psychol. Bull. 1993, 113:472-486.
131. Herbert T., Cohen S. Stress and immunity in humans: A meta-analytic review. Psychosom. Med. 1993, 55:364-379.
132. Hernandez-Reif M., Ironson G., et al. Breast cancer patients have improved immune and neuroendocrine functions following massage therapy. J. Psychosom. Res. 2004, 57(1):45-52.
133. Hidderley M., Holt M. A pilot randomized trial assessing the effects of autogenic training in early stage cancer patients in relation to psychological status and immune system resp. Eur. J. Oncol. Nurs. 2004, 8:61-65.
134. Hou J., Zheng W.F. Effect of sex hormones on NK and ADCC activity of mice. Int. J. Immunopharmacol. 1988, 10(1):15-22.
135. Huang L.M., Chao M.F., Chen M.Y., Shih H.M., Chiang Y.P., Chuang C.Y., et al. Reciprocal regulatory interaction between Human Herpesvirus 8 and Human Immunodeficiency Virus Type 1. J. Biol. Chem. 2001, 276:13427-13432.
136. Ironson G., Antoni M.H., Lutgendorf S. Coping: interventions for optimal disease management. Innovative approaches to health psychology: prevention and treatment lessons from AIDS 2002, American Psychological Association Press, Washington, DC. M. Chesney, M. H. Antoni (Eds.).
137. Ironson G., Balbin E., Solomon G., Fahey J., Klimas N., Schneiderman N., Fletcher M.A. Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 counts. AIDS 2001, 15:2065-2073.
138. Ironson G., Field T., Scafidi F., Hashimoto M., Kumar M., Kumar A., Price A., Goncalves A., Burman R., Tetenman C., Patarca R., Fletcher M.A. Massage therapy is associated with enhancement of the immune system's cytotoxic capacity. Int. J. Neurosci. 1996, 84:205-217.
139. Ironson G., Friedman A., Klimas N., et al. Distress, denial, and low adherence to behavioral intervention predict factor disease progression in gay men infected with HIV. Int. J. Beh. Med. 1994 1994, 1(1):90-105.
140. Ironson G., Solomon G., Cruess D., Barroso J., Stivers M. Psychosocial factors related to long-term survival in HIV/ AIDS. Clin. Psychol. Psychother. 1995, 2:249-266.
141. Ironson G., Wynings C., Schneiderman N., Baum A., Rodriquez M., Greenwood D., Benight C., Antoni M.H., LaPerriere A., Huang H., Klimas N., Fletcher M. Post traumatic stress symptoms, intrusive thoughts, loss and immune function after Hurricane Andrew. Psychosom. Med. 1997, 59:128-141.
142. Irwin M., Brown M., Patterson T., Hauger R., Mascovich A., Grant I. Neuropeptide Y and natural killer activity, Findings in depression and Alzheimer caregiver stress. FASEB J. 1992, 5:3100-3107.
143. Irwin M., Daniels M., Smith T., Bloom E., Weiner H. Impaired natural killer cell activity during bereavement. Brain Behav. Immun. 1987, 1:98-104.
144. Jacobsen P., Hann D. Cognitive-behavioral interventions. Textbook of psycho-oncology 1998, 717-729. Oxford Press, New York. J. Holland (Ed.).
145. Jensen M. Psychobiological factors predicting the course of breast cancer. J. Pers. 1987, 55:317-342.
146. Kemeny M.E. Stressful events, psychological responses and progression of HIV infection. Handbook on stress and immunity 1994, 245-266. Academic Press, New York. R. Glaser, J. Kiecolt-Glaser (Eds.).
147. Kiecolt-Glaser J., Dura J.R., Speicher C.E., Trask O.J., Glaser R. Spousal caregivers of dementia victims: longitudinal changes in immunity and health. Psychosom. Med. 1991, 53:345-362.
148. Kiecolt-Glaser J., Fisher L., Ogrocki P., Stout J., Speicher C., Glaser R. Marital quality, marital disruption, and immune function. Psychosom. Med. 1987, 49:13-34.
149. Kiecolt-Glaser J., Glaser R. Psychological influences on immunity: implications for AIDS. Am. Psychol 1988, 43:892-898.
150. Kiecolt-Glaser J., Glaser R., Williger D. Psychosocial enhancement of immunocompetence in a geriatric population. Health Psychol. 1985, 4:25-41.
151. Kiecolt-Glaser J., Glaser R., Strain E., Stout J., Tarr K., Holliday J., Speicher C. Modulation of cellular immunity in medical students. J. Behav. Med. 1986, 9:311-320.
152. Kiecolt-Glaser J.K., Kennedy S., Malkoff S., Fisher L., Speicher C.E., Glaser R. Marital discord and immunity in males. Psychosom. Med. 1988, 50:213-229.
153. Kiecolt-Glaser J., Malarkey W., Cacioppo J., Glaser R. Stressful personal relationships: endocrine and immune function. Handbook of human stress and immunity 1994, 321-339. Academic Press, San Diego, CA. R. Glaser, J. Kiecolt-Glaser (Eds.).
154. Kiecolt-Glaser J., Malarkey W., Chee M., et al. Negative behavior during marital conflict is associated with immunological down regulation. Psychosom. Med. 1993, 55:395-409.
155. Kiecolt-Glaser J., Marucha P., Malarkey W., Mercado A., Glaser R. Slowing of wound healing by psychological stress. Lancet 1995, 346:1194-1196.
156. Kiecolt-Glaser J., Ricker D., George J., Messick G., Speicher C., Garner W., Glaser R. Urinary cortisol levels, cellular immunocompetency, and loneliness in psychiatric inpatients. Psychosom. Med. 1984, 46(1):15-23.
157. Kiecolt-Glaser J.K., Robles T.F., et al. Psycho-oncology and cancer: psychoneuroimmunology and cancer. Ann. Oncol 2002, 13(Suppl 4):165-169.
158. Killebrew D., Shiramizu B. Pathogenesis of HIVassociated non-Hodgkin lymphoma. Curr. HIV Res. 2004, 2:215-221.
159. Klimas N., Caralis P., LaPerriere A., Antoni M., Ironson G., Simoneau J., Schneiderman N., Fletcher M.A. Immunologic function in a cohort of HIV Type-1 seropositive and negative healthy homosexual men. J. Clin. Microbiol. 1991, 29:1413-1421.
160. Kobasa S., Maddi S., Puccetti M., Zola M. Effectiveness of hardiness, exercise, and social support as resources against illness. J. Psychosom. Res. 1985, 29(5):525-533.
161. Kopinsky K.L., Stoff D.M., Rausch D.M. Workshop report: the effects of psychological variables on the progression of HIV-1 disease. Brain Behav. Immun. 2004, 18:246-261.
162. Kurtzman S., Miller L., Anderson K., Wang P., Kreutzer D. Cytokine regulation of angiogenesis in human breast cancer. Proceedings of the Dept. of Defense Breast Cancer Research Program Meeting "Era of Hope," 1997, 341-342.
163. LaPerriere A., Antoni M.H., Schneiderman N., Ironson G., et al. Exercise intervention attenuates emotional distress and natural killer cell decrements following notification of positive serologic status for HIV-1. Biofeedback and Self-Regulation 1990, 15(3):229-242.
164. LaPerriere A., Goldstein A., Klimas N., Ironson G., Major P., Maik G., Talluto C., Fletcher M.A., Schneiderman N. Non compliant exercise decreases CD4 cells in early symptomatic HIV-1 infection. the Society of Behavioral Medicine 1997, April, Paper presented at.
165. Larson M., Duberstein P., Talbot N., Caldwell C., Moynihan J. A pre-surgical psychosocial intervention for breast cancer patients: psychological distress and the immune response. J. Psychosom. Res. 2000, 48:187-194.
166. Larson S.J., Dunn A.J. Behavioral effects of cytokines. Brain Behav. Immun. 2001, 15:371-387.
167. Lechner S., Antoni M.H., Lydston D., LaPerriere A., Ishii M., Stanley H., Ironson G., Schneiderman N., Brondolo E., Tobin J., Weiss S. Cognitive-behavioral interventions improve quality of life in women with AIDS. J. Psychosom. Res. 2003, 54:253-261.
168. Lepore S.J., Eton D.V., Helgeson V.S., Schulz R. Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychol. 2003, 22(5):443-452.
169. Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol. Psychiatry 2003, 54:295-306.
170. Leserman J., Petitto J., Perkins D., Folds J., Golden R., Evans D. Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. Arch. Gen. Psychiatry 1997, 54:279-285.
171. Lésperance F., Frasure-Smith N., Talajic M., Bourassa M.G. Five-year risk of cardiac mortality in relation to initial severity and one-year change in depression symptoms after myocardial infarction. Circulation 2002, 105:1049-1053.
172. Lésperance F., Frasure-Smith N., Theroux P., Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6 and c-reactive protein in patients with recent coronary syndromes. Am. J. Psychiatry 2004, 161:271-277.
173. Levy S., Herberman R., Lippman M., D'Angelo T., Lee J. Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Beh. Med. 1991, 17:67-75.
174. Levy S., Herberman R., Whiteside T., et al. Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural
175. Lewin D. Protease inhibitors: HIV-1 summons a Darwinian defense. J. NIH Res. 1996, 8:33-35.
176. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
177. Linden W., Stossel C., Maurice J. Psychosocial interventions for patients with coronary artery disease. Arch. Intern. Med. 1996, 156:745-752.
178. Lutgendorf S., Antoni M.H., Ironson G., Fletcher M.A., Penedo F., VanRiel F., Baum A., Schneiderman N., Klimas N. Physical symptoms of chronic fatigue syndrome are exacerbated by the stress of Hurricane Andrew. Psychosom. Med. 1995, 57:310-323.
179. Lutgendorf S., Antoni M., Ironson G., Klimas N., Kumar M., Starr K., McCabe P., Cleven K., Fletcher M., Schneiderman N. Cognitive-behavioral stress management decreases dysphoric mood and herpes simplex virus-Type 2 antibody titers in symptomatic HIV-seropositive gay men. J. Consult. Clin. Psychol. 1997, 64:31-43.
180. Lutgendorf S., Antoni M., Ironson G., Starr K., Costello N., Zuckerman M., Klimas N., Fletcher M., Schneiderman N. Changes in cognitive coping skills and social support during cognitive behavioral stress management intervention and distress outcomes in symptomatic human im ciency virus (HIV) -seropositive gay men. Psychosom. Med. 1998, 60(2):204-214.
181. Lutgendorf S., Antoni M., Kumar M., Schneiderman N. Changes in cognitive coping strategies predict EBV-antibody titre change following a stressor disclosure induction. J. Psychosom. Res. 1994, 38(1):63-78.
182. Lutgendorf S., Cole S., Costanzo E., et al. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin. Cancer Res. 2003, 9:4514-4521.
183. Lutgendorf S., Johnsen E., Holmes R., Anderson B., Sorosky J., Buller R., Sood A. Social relationships and tumor angiogenesis factors in ovarian cancer patients. Cancer 2002, 95:808-815.
184. Maier S.F., Watkins L.R. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol. Rev. 1998, 105:83-107.
185. Maier S.F., Watkins L., Fleshner M. Psychoneuroimmunology: the interface between behavior, brain, and immunity. Am. Psychol. 1994, 49:1004-1017.
186. Maiman M., Fruchter R. Cervical neoplasia and the human immunodeficiency virus. Cervical cancer and preinvasive neoplasia 1996, 405-416. Lippincott-Raven, Philadelphia. S. Rubino, W. Hoskins (Eds.).
187. Masek K., Petrovicky P., Seifert J. An introduction to the possible role of central nervous system structures in neuroendocrine-immune systems interaction. Int. J. Immunopharmacol. 1992, 14:317-322.
188. McEwen B. Protective and damaging effects of stress mediators. N. Engl. J. Med. 1998, 338:171-179.
189. McGrady A., Woerner M., Bernal G.A.A., Higgins J.T. Effect of biofeedback-assisted relaxation on blood pressure and cortisol levels in normotensives and hypertensives. J. Behav. Med. 1987, 10:301-310.
190. McGregor B., Antoni M.H., Boyers A., Alferi S., Cruess D., Blomberg B., Carver C.S. Effects of cognitive behavioral stress management on immune function and positive contributions in women with early-stage breast cancer. J. Psychosom. Res. 2004, 54:1-8.
191. McKinney C., Antoni M.H., Kumar M., Tims F., McCabe P. Effects of guided imagery and music (GIM) therapy on mood and cortisol in healthy adults. Health Psychol. 1997, 16(4):1-12.
192. McKinnon W., Weisse C.S., Reynolds C.P., Bowles C.A., Baum A. Chronic stress, leukocyte subpopulations, and humoral response to latent viruses. Health Psychol. 1989, 8:399-402.
193. Mendes de Leon C.F., Powell L.H., Kaplan B.H. Change in coronary-prone behaviors in the recurrent coronary prevention project. Psychosom. Med. 1991, 53:407-419.
194. Miller G.E., Cohen S., Ritchey A.K. Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol. 2002, 21:531-541.
195. Mohr D.C., Hart S.L., Julian L., Cox D., Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. Br. Med. J. 2004, 328:731.
196. Morgan W. Psychological effects of exercise. Behav. Med. Update 1982, 4:25-30.
197. Morrow D.A., Ridker P.M. C-reactive protein, Inflammation, and coronary disease. Med. Clin. North Am. 2000, 81:149-161.
198. Mulder C., Antoni M.H., Duivenvoorden H., Kauffmann R., Goodkin K. Active confrontational coping predicts decreased clinical progression over a one-year period in HIV-infected homosexual men. J. Psychosom. Res. 1995, 39:957-965.
199. Mulder C., de Vroome E., van Griensven G., Antoni M.H., Sandfort T. Distraction as a predictor of the virological course of HIV-1 infection over a 7-year period in gay men. Health Psychol. 1999, 18:107-113.
200. Mulder N., Antoni M., Emmelkamp P., Veugelers P., Sandfort T., van der Vijver F., de vries M. Psychosocial group intervention and the rate of decline of immunologic parameters in asymptomatic HIV-infected homosexual men. J. Psychother. Psychosom. 1995, 63:185-192.
201. Mullen P.D., Mains D.A., Velez R. A meta-analysis of controlled trials of cardiac patient education. Patient Educ. Couns. 1992, 19:143-162.
202. Myers J.K., Weissman M.M., Tischler G.L., et al. Six month prevalence of psychiatric disorders in three communities, 1980 to 1982. Arch. Gen. Psychiatry 1984, 41:959-967.
203. Oesterling E., Oesterling J.E. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J. Urol. 1991, 143:907-923.
204. O'Neill B., Leonard B. Is there an abnormality in neutrophil phagocytosis in depression?. IRCS Med. Sci. 1986, 14:802-803.
205. Osanto S., Brouwenstyn N., Vessen N., Figdor C., Melief C., Schrier P. Clinical protocol. Immunization with interleukin-2-transfected melanoma cells. A phase I-II study of patients with metastatic melanoma. Hum. Gene Ther. 1993, 4:323-330.
206. Parker J., Frank R., Beck N., Smarr K., Beuscher K., Phillips L., Smith E., Anderson S. Pain management in rheumatoid arthritis: a cognitive-behavioral approach 1987, Unpublished manuscript, Washington University.
207. Pavlidis N., Chirigos M. Stress-induced impairment of macrophage tumoricidal function. Psychosom. Med. 1980, 42(1):47-54.
208. Payne D., Hoffman R., Theodoulou M., Dosik M., Massie M. Screening for anxiety and depression in women with breast cancer. Psychosomatics 1999, 40:64-69.
209. Penedo F.J., Dahn J., Gonzalez J.S., Molton I., Schneiderman N., Antoni M.H. Personality relates to mood states, quality of life and immune function in men who underwent prostate cancer surgery. Ann. Beh. Med. 2002, 24:S186. [Abstract].
210. Penedo F.J., Dahn J., Kinsinger D., Antoni M.H., Molton I., Gonzalez J.S., Fletcher M.A., Roos B., Carver C., Schneiderman N. Anger suppression mediates the relationship between optimism and natural killer cell cytotoxicity in men treated for localized prostate cancer. J. Psychosom Res. 2006, 60:423-427.
211. Penedo F.J., Dahn J.R., Molton I., Gonzalez J., Roos B., Schneiderman N., Antoni M. Cognitive-behavioral stress management improves quality of life and stress management skill in men treated for localized prostate cancer. Cancer 2004, 100:192-200.
212. Penedo F.J., Gonzalez J.S., Duran R., Dahn J.R., Mendiola M., Thomas E., Antoni M.H., Schneiderman N. Illnessrelated spousal/marital disruption relates to psychological distress and immune function in men treated with radical prostatectomy for prostate cancer. Psychosom. Med. 2002, 64(1):158.
213. Pennebaker J.W., Kiecolt-Glaser J.K., Glaser R. Disclosure of traumas and immune function: health implications for psychotherapy. J. Consult. Clin. Psychol. 1988, 56:239-245.
214. Pereira D. Interventions for mothers during pregnancy and postPARTum: behavioral and pharmacological approaches. Innovative approaches to health psychology: prevention and treatment lessons from AIDS 2002, 141-166. American Psychological Association Press, Washington, DC. M. Chesney, M. H. Antoni (Eds.).
215. Pereira D., Antoni M.H., Danielson A., Simon T., Munajj J., Efantis-Potter J., O'Sullivan M.J. Declines in natural killer cell percentages mediate the effects of high life stress on the incidence of cervical dysplasia in HIV+ black women at risk for cer. Psychosom. Med. 2000, 62:105.
216. Pereira D., Antoni M.H., Simon T., Efantis-Potter J., Carver C., Duran R., Ironson G., Klimas N., O'Sullivan M.J. Stress as a predictor of symptomatic genital herpes virus recur-rence in women with human immunodeficiency virus. J. Psychosom. Res. 2003, 54:237-244.
217. Pereira D., Antoni M.H., Simon T., Efantis-Potter J., Carver C.S., Duran R., Ironson G., Klimas N., O'Sullivan M.J. Stress and squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virus. Psychosom. Med. 2003, 65:427-434.
218. Pereira D., Antoni M.H., Simon T., Potter J., O'Sullivan M.J. Cognitive behavioral stress management effects on regression of cervical dysplasia among HIV+ women. the American Psychosomatic Society meeting 2005, March, Paper presented at.
219. Petrie K., Fonanilla I., Thomas M.G., Booth R.J., Pennebaker J. Effect of written emotional expression on immune function in patients with human immunodeficiency virus infection: a randomized trial. Psychosom. Med. 2004, 66:272-275.
220. Petrie K.J., Booth R.J., Pennebaker J.W., Davidson K.P., Thomas M.G. Disclosure of trauma and immune response to a hepatitis B vaccination program. J. Consult. Clin. Psychol. 1995, 63(5):787-792.
221. Pettingale K.W., Morris T., Greer S., Haybittle J.L. Mental attitudes to cancer: an additional prognostic factor. Lancet 1985, 1:750.
222. Pope R. Immunoregulatory mechanisms present in the maternal circulation during pregnancy. Baillieres Clin. Rheumatol. 1990, 4:33-52.
223. Portenoy R., Miaskowski C. Assessment and management of cancer-related fatigue. Principles and practice of supportive oncology 1998, 109-1180. Lippincott-Raven, New York. A. Berger (Ed.).
224. Ramirez A., Craig T., Watson J., Fentiman I., North W., Rubens R. Stress and relapse of breast cancer. Br. Med. J. 1989, 298:291-293.
225. Redwine L., Snow S., Mills P., Irwin M. Acute psychological stress: effects on chemotaxis and cellular adhesion molecule expression. Psychosom. Med. 2003, 65:598-603.
226. Reed G., Kemeny M., Taylor S.E., Wang H.J., Visscher B. Realistic acceptance as a predictor of decreased survival time in gay men with AIDS. Health Psychol. 1994, 13:299-307.
227. Rivest S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 2001, 26:761-788.
228. Rogentine G., Van Krammen D., Fox B., Docherty J., Rosenblatt J., Boyd S., Bunney W. Psychological factors in the prognosis of malignant melanoma: a prospective study. Psychosom. Med. 1979, 4:647-655.
229. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
230. Rozanski A., Blumenthal J.A., Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999, 99:2192-2217.
231. Rugulies R. Depression as a predictor for coronary heart disease. Am. J. Preven. Med. 2002, 23:51-61.
232. Rush A.J., Beck A.T., Kovacs M., Weissenburger J., Hollon S.D. Comparison of the effects of cognitive therapy and pharmacotherapy on hopelessness and self-concept. Am. J. Psychiatry 1982, 139:862-866.
233. Schedlowski M., Jungk C., Schimanski G., Tewes U., Schmoll H. Effects of behavioral intervention on plasma cortisol and lymphocytes in breast cancer patients: an exploratory study. Psycho-oncology 1994, 3:181-187.
234. Schleifer S.J., Macari-Hinson M.M., Coyle D.A., et al. The nature and course of depression following myocardial infarction. Arch. Intern. Med. 1989, 149:1785-1789.
235. Schlenzig C., Jager H., Rieder H., et al. Supervised physical exercise leads to psychological and immunological improvement in pre-AIDS patients. Proceedings of the 5th International AIDS Conference 1989, June.
236. Schneiderman N., Antoni M., Saab P., Ironson G. Health psychology: psychosocial and biobehavioral aspects of chronic disease management. Ann. Rev. Psychol. 2001, 52:555-580.
237. Schneiderman N., Antoni M.H., Ironson G. Cognitive behavioral stress management and secondary prevention in HIV/AIDS. Psychol. AIDS Exchange 1997, 22:1-8.
238. Sheridan J. Viral models of neuroendocrine/immune interactions. Mind-Body interactions and disease and psychoneuroimmunological aspects of health and disease. Proceedings of conference on Stress, Immunity and Health. Natio Institutes of Health 1996, 199-204. Heath Dateline Press, Washington, DC. N. Hall, F. Altman, S. Blumenthal, S. Blumenthal (Eds.).
239. Simons A.D., Garfield S., Murphy G.E. The process of change in cognitive therapy and pharmacotherapy for depression. Changes in mood and cognition. Arch. Gen. Psych. 1984, 41:45-51.
240. Smyth J.M. Written emotional expression: effect sizes, outcome types, and moderating effects. J. Consult. Clin. Psychol. 1998, 66:174-184.
241. Smyth J.M., Stone A.A., Hurewitz A., Kaell A. Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a randomized trial. JAMA 1999, 281:1304-1309.
242. Solomon G., Segerstrom S., Grohr P., Kemeny M., Fahey J. Shaking up immunity: psychological and immunologic changes after a natural disaster. Psychosom. Med. 1997, 59:114-127.
243. Spiegel D. Effects of psychotherapy on cancer survival. Nat. Rev. Cancer 2002, 2(5):383-389.
244. Spiegel D., Bloom J., Kraemer H.C., Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989, 2:888-891.
245. Spiegel D., Bloom J., Yalom I. Group support for patients with metastatic cancer: A randomized prospective outcome study. Arch. Gen. Psychiatry 1981, 38(5):527-533.
246. Spiegel D., Glafkides M. Effects of group confrontation with death and dying. Int. J. Group Psychother. 1983, 33(4):433-447.
247. Stanton A., Danoff-Burg S., Sworowski L.A., et al. Randomized, controlled trial of written emotional expression and Benefit finding in breast cancer patients. J. Clin. Oncol. 2002, 20:4160-4168.
248. Starr K., Antoni M.H., Hurwitz B., Rodriguez M., Ironson G., Fletcher M.A., Kumar M., Patarca R., Lutgendorf S., Quillian R., Klimas N., Schneiderman N. Patterns of immune, neuroendocrine, and cardiovascular stress responses in HIV seropositive and seronegative men. Int. J. Behav. Med. 1996, 3:135-162.
249. Steptoe A., Brydon L. Psychoneuroimmunology and coronary heart disease. Human psychoneuroimmunology 2005, 107-136. Oxford University Press, Oxford. K. Vedhara, M. Irwin (Eds.).
250. Steptoe A., Willemsen G., Owen N., Flower L., Mohamed-Ali V. Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels. Clin. Sci. 2001, 101:185-192.
251. Sternberg E. Inflammatory disease and rheumatoid arthritis. Mind-body interactions and disease and psychoneuroimmunological aspects of health and disease. Proceedings of conference on Stress, Immunity and Health. Natio Institutes of Health 1996, 105-115. Heath Dateline Press, Washington, DC. N. Hall, F. Altman, S. Blumenthal (Eds.).
252. Stites D., Stobo J., Fudenberg H., Wells J. Basic and clinical immunology 1982, Lange, Los Altos, CA. 4th ed.
253. Sulke A.N., Jones D.B., Wood P.J. Variation in natural killer activity in peripheral blood during the menstrual cycle. Brit. Med. J. (Clinical Research Ed. 1985, ) 290:884-886.
254. Suligoi B., Dorrucci M., Uccella I., Andreoni M., Rezza G., the Italian Seroconversion Study. Effect of multiple herpesvirus infections on the progression of HIV disease in a cohort of HIV seroconverters. J. Med. Virol. 2003, 69:182-187.
255. Surwit R.S., Feinglos M.N. The effects of relaxation on glucose tolerance in non-insulin-dependent diabetes. Diabetes Care 1983, 6:176-179.
256. Taylor C.B., Youngblood M.E., Catellier D., Veith R.C., Carney R.M., Burg M.M., Kaufmann P.G., Shuster J., Mellman T., Blumenthal J.A., Krishnan R., Jaffe A.S.for the ENRICHD Investigators. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch. Gen. Psychiatry 2005, 62:792-798.
257. Taylor D.N. Effects of a behavioral stress management program on anxiety, mood, self-esteem, and T-cell count in HIVpositive men. Psychol. Rep. 1995, 76:451-457.
258. Theorell T., Blomkvist V., Jonsson H., Schulman S., Berntorp E., Stigendal L. Social support and the development of immune function in human immunodeficiency virus infection. Psychosom. Med. 1995, 57:32-36.
259. Tichatschek E., Zielinski C., Muller C., Sevelda P., Kubista E., Czerwenka K., Spona J., Wolf H., Eibl M. Longterm influence of adjuvant therapy on natural killer cell activity in breast cancer. Immunotherapy 1988, 27:278-282.
260. Turk D., Holzman A., Kerns R. Chronic pain. Self management of chronic disease: handbook of clinical interventions and research 1986, Academic Press, Inc., Orlando, FL. K. Holroyd, T. Creer (Eds.).
261. Van der Pompe G., Antoni M., Heijnen C. The effects of surgical stress and psychological stress on the immune function of operative cancer patients. Psychol. Health 1998, 13:1015-1026.
262. Van der Pompe G., Antoni M.H., Mulder N., Heijnen C., Goodkin K., de Graeff A., Garssen B., de Vries M. Psychoneuroimmunology and the course of breast cancer, an overview: the impact of psychosocial factors on progression of breast cancer through immune and endo mechanisms. Psycho-oncology 1994, 3:271-288.
263. Van der Pompe G, Antoni M.H., Visser A., Heijnen C., deVries M. Psychological and immunological effects of psychotherapy for breast cancer patients: a reactivity study. Psychosom. Med. 1996, 58:97. (abstract).
264. Van der Pompe G., Duivenvoorden H., Antoni M.H., Visser A., Heijnen C. Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: an exploratory study. J. Psychosom. Res. 1997, 42:453-466.
265. Van Der Ven A., Van Diest R., Hamulyak K., Maes M., Bruggeman C., Appels A. Herpes viruses, cytokines, and altered hemostasis in vital exhaustion. Psychosom. Med. 2003, 65:194-200.
266. Veith R.C., Lewis N., Linares O.A., Barnes R.F., Raskind M.A., Villacres E.C., Murburg M.M., Ashleigh E.A., Castillo S., Peskind E.R., Halter J.B. Sympathetic nervous system activity in major depression: basal and desipramineinduced alterations in plasma norepinephrine kinetics. Arch. Gen. Psychiatry 1994, 51:411-422.
267. Walker L.G., Walker M., Ogston K., Heys S., Ah-See A., Miller I., et al. Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy. Brit. J. Cancer 1999, 80:262-268.
268. Watkins L., Wiertelak E., Goehler L., Mooney-Heiberger K., Martinez J., Furness L., Smith K., Maier S. Neurocircuitry of illness-induced hyperalgesia. Brain Res. 1994, 639:283-299.
269. Watson M., Haviland J., Greer S., Davidson J., Bliss J. influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 1999, 354:1331-1336.
270. Weisse C. Depression and immunocompetence: a review of the literature. Psychol Bull. 1992, 111:475-489.
271. Whitacre C., Cummings S., Griffin A. The effects of stress on autoimmune disease. Handbook of human stress and immunity 1994, 77-100. Academic Press, New York. R. Glaser, J. Kiecolt-Glaser (Eds.).
272. Wiedenfeld S., O'Leary A., Bandura A., Brown S., Levine S., Raska K. Impact of perceived self-efficacy in coping with stressors on components of the immune system. J. Pers. Soc. Psy 1990, 59:1082-1094.
273. Williams R.B., Barefoot J.C., Califf R.M., Haney T.L., Saunders W.B., Pryor D.B., Hlatky M.A., Siegler I.C., Mark D.B. Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. J. Am. Med. Assoc. 1992, 267:520-524.
274. Wojciechowski F.L., Strik J.J.M.H., Falger P., Lousberg R., Honig A. The relationship between depressive and vital exhaustion symptomatology post-myocardial infarction. Acta Psychiatr. Scand. 2000, 102:359-365.
275. Yang E., Glaser R. Wound healing and psychoneuroimmunology. Human psychoneuroimmunology 2005, 265-284. Oxford University Press, Oxford. K. Vedhara, M. Irwin (Eds.).
276. Zachariae R., Hansen J.B., Andersen M. Changes in cellular immune function after immune specific guided imagery and relaxation in high and low hypnotizable healthy subjects. Psychother. Psychosom. 1994, 61:74-92.
277. Zuckerman M., Antoni M.H. Social support and its relationship to psychological, physical and immune variables in HIV infection. Clin. Psychol. Psychother. 1995, 2(4):210-219.
278. Zwilling B. Effects of stress on the course of mycobacterial infections including tuberculosis. Mind-body interactions and disease and psychoneuroimmunological aspects of health and disease. National Institutes of Health 1996, Heath Dateline Press, Washington, DC. N. Hall, F. Altman, S. Blumenthal (Eds.).